GE HealthCare (GEHC) Tops Q3 EPS by 9c; raises guidance

GE HealthCare (NASDAQ: GEHC) reported Q3 EPS of $1.14, $0.09 better than the analyst estimate of $1.05. Revenue for the quarter came in at $4.86 billion versus the consensus estimate of $4.87 billion.

GUIDANCE:

GE HealthCare sees FY2024 EPS of $4.25-$4.35, versus prior guidance of $4.20-$4.35 and the consensus of $4.25.

For earnings history and earnings-related data on GE HealthCare (GEHC) click here.

You May Also Be Interested In

• Goldman Sachs Upgrades China Resources Microelectronics Ltd (688396:CH) to Neutral
• DoorDash (DASH) Reiterated at Market Outperform by Citizens on Channel Connected Launch
• Goldman Sachs Double Upgrades Bradsaude SA (SAUD3:BZ) to Buy